Sitazid M 50 mg+500 mg (Tablet)
Unit Price: ৳ 14.00 (2 x 10: ৳ 280.00)
Strip Price: ৳ 140.00
Medicine Details
Category | Details |
---|---|
Generic | Sitagliptin metformin hydrochloride |
Company | Eskayef pharmaceuticals ltd |
Also available as |
Title
- Oral Diabetes Medication
Categories
- Medicine
- Health
- Diabetes Care
Description
- Combines two antihyperglycemic agents with complementary mechanisms of action to improve glycemic control in patients with type 2 diabetes.
Dimensions
- Film-coated tablet
- Extended-release tablet
Color Options
- None
Functions
- Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
- Decreases hepatic glucose production
- Decreases intestinal absorption of glucose
- Increases peripheral glucose uptake and utilization
Materials
- Sitagliptin
- Metformin HCl
Technical Specifications
- Maximum recommended daily dose of 100 mg sitagliptin and 2000 mg metformin
- Administered twice daily with meals
- Individualized dosage based on patient's current regimen
- Cautious use with cationic drugs eliminated by renal tubular secretion
Design Elements
- Film-coated tablet
- Extended-release tablet
Usability Features
- Individualized dose escalation to reduce gastrointestinal side effects due to metformin
- Temporary discontinuation in patients undergoing radiologic studies involving intravascular administration of iodinated contrast materials
Interactions
- Cationic drugs - use with caution
- Possible influence on phenprocoumon and levothyroxine effectiveness
Contraindications
- Renal disease or dysfunction
- Acute or chronic metabolic acidosis
- History of serious hypersensitivity reactions
- Use during radiologic studies involving iodinated contrast materials
Side Effects
- Diarrhea
- Upper respiratory tract infection
- Headache
- Hypoglycemia
- Nasopharyngitis
- Nausea/vomiting
- Flatulence
- Abdominal discomfort
- Indigestion
- Asthenia
Pregnancy & Lactation
- Pregnancy Category B
- Caution during lactation
Precautions & Warnings
- Lactic Acidosis risk
- Regular monitoring of thyroid-stimulating hormone (TSH) levels
- Long-term treatment associated with decrease in vitamin B12 serum levels
- Postmarketing reports of acute renal failure and pancreatitis
- Hematologic parameters monitoring
- Caution against excessive alcohol intake
- Potential allergic and hypersensitivity reactions
- No conclusive evidence of macrovascular risk reduction
Overdose Effects
- Supportive measures in case of overdose
- Dialyzable in case of overdose
Therapeutic Class
- Combination Oral hypoglycemic preparations
Storage Conditions
- Store below 25°C in a dry place away from light
- Keep out of reach of children
- Do not use after expiry date
Related Brands
- Sitazid M 50 mg+1000 mg (Tablet) - eskayef-pharmaceuticals-ltd
- Sitalia M XR 50 mg+500 mg (Tablet (Extended Release)) - delta-pharma-ltd
- Glipita M XR 50 mg+500 mg (Tablet (Extended Release)) - beximco-pharmaceuticals-ltd
- Sliptin-M ER 50 mg+1000 mg (Tablet (Extended Release)) - drug-international-ltd
- Sliptin-M ER 50 mg+500 mg (Tablet (Extended Release)) - drug-international-ltd